Reduced-Intensity Conditioning for Children and Adults with Hemophagocytic Syndromes or Selected Primary Immune Deficiencies

Trial Profile

Reduced-Intensity Conditioning for Children and Adults with Hemophagocytic Syndromes or Selected Primary Immune Deficiencies

Recruiting
Phase of Trial: Phase II

Latest Information Update: 28 Nov 2014

At a glance

  • Drugs Alemtuzumab (Primary) ; Ciclosporin (Primary) ; Fludarabine (Primary) ; Melphalan (Primary) ; Methylprednisolone (Primary)
  • Indications Chronic granulomatous disease; Haemophagocytic lymphohistiocytosis; Leucocyte disorders
  • Focus Therapeutic Use
  • Acronyms RICHI
  • Most Recent Events

    • 28 Nov 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top